company background image
AG8 logo

Agilent Technologies DB:AG8 Stock Report

Last Price

€134.00

Market Cap

€39.9b

7D

-0.6%

1Y

8.9%

Updated

25 Mar, 2024

Data

Company Financials +

Agilent Technologies, Inc.

DB:AG8 Stock Report

Market Cap: €39.9b

AG8 Stock Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

AG8 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Agilent Technologies, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Agilent Technologies
Historical stock prices
Current Share PriceUS$134.00
52 Week HighUS$136.65
52 Week LowUS$94.96
Beta1.11
1 Month Change10.24%
3 Month Change6.82%
1 Year Change8.87%
3 Year Change26.25%
5 Year Change87.57%
Change since IPO527.49%

Recent News & Updates

Recent updates

Shareholder Returns

AG8DE Life SciencesDE Market
7D-0.6%4.1%1.6%
1Y8.9%-5.0%6.4%

Return vs Industry: AG8 exceeded the German Life Sciences industry which returned -3.7% over the past year.

Return vs Market: AG8 exceeded the German Market which returned 6.4% over the past year.

Price Volatility

Is AG8's price volatile compared to industry and market?
AG8 volatility
AG8 Average Weekly Movement3.5%
Life Sciences Industry Average Movement6.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: AG8 has not had significant price volatility in the past 3 months.

Volatility Over Time: AG8's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199917,700Mike McMullenhttps://www.agilent.com

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Agilent Technologies, Inc. Fundamentals Summary

How do Agilent Technologies's earnings and revenue compare to its market cap?
AG8 fundamental statistics
Market cap€39.87b
Earnings (TTM)€1.14b
Revenue (TTM)€6.21b

34.5x

P/E Ratio

6.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AG8 income statement (TTM)
RevenueUS$6.74b
Cost of RevenueUS$3.33b
Gross ProfitUS$3.41b
Other ExpensesUS$2.17b
EarningsUS$1.24b

Last Reported Earnings

Jan 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.22
Gross Margin50.56%
Net Profit Margin18.35%
Debt/Equity Ratio41.3%

How did AG8 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

22%

Payout Ratio

Does AG8 pay a reliable dividends?

See AG8 dividend history and benchmarks
When do you need to buy AG8 by to receive an upcoming dividend?
Agilent Technologies dividend dates
Ex Dividend DateApr 01 2024
Dividend Pay DateApr 24 2024
Days until Ex dividend5 days
Days until Dividend pay date28 days

Does AG8 pay a reliable dividends?

See AG8 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.